Protracted cisplatin-induced vomiting responding to mosapride.
Ganesan
P
P
Sharma
A
A
Mohanti
B K
BK
Gogia
A
A
D000328:Adult; D000471:Alkalosis / Q000209:etiology; D000932:Antiemetics / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001549:Benzamides / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002277:Carcinoma / Q000628:therapy; D002945:Cisplatin / Q000009:adverse effects*; D003131:Combined Modality Therapy; D003681:Dehydration / Q000209:etiology; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D006996:Hypocalcemia / Q000209:etiology; D007008:Hypokalemia / Q000209:etiology; D008787:Metoclopramide / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use*; D009303:Nasopharyngeal Neoplasms / Q000628:therapy; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy; D009367:Neoplasm Staging; D017294:Ondansetron / Q000627:therapeutic use; D017239:Paclitaxel / Q000008:administration & dosage; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D011878:Radiotherapy; D014839:Vomiting / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents; D001549:Benzamides; D005765:Gastrointestinal Agents; D009025:Morpholines; D017294:Ondansetron; D003907:Dexamethasone; D016190:Carboplatin; C062720:mosapride; D008787:Metoclopramide; D017239:Paclitaxel; D002945:Cisplatin